BerandaGBM • FRA
add
Inovio Pharmaceuticals Inc
Tutup sebelumnya
€1,56
Rentang hari
€1,57 - €1,57
Rentang tahun
€1,57 - €12,14
Kapitalisasi pasar
63,43Â jt USD
Volume Rata-Rata
265,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 116,99Â rb | 13,97% |
Biaya operasional | 7,60Â jt | 37,12% |
Laba bersih | -19,38Â jt | 22,48% |
Margin laba bersih | -16,57Â rb | 31,99% |
Penghasilan per saham | -0,60 | 89,42% |
EBITDA | -19,95Â jt | 9,81% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 94,11Â jt | -35,23% |
Total aset | 113,20Â jt | -33,78% |
Total liabilitas | 44,69Â jt | -16,62% |
Total ekuitas | 68,50 jt | — |
Saham yang beredar | 36,67 jt | — |
Harga terhadap nilai buku | 0,82 | — |
Tingkat pengembalian aset | -46,24% | — |
Tingkat pengembalian modal | -61,22% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -19,38Â jt | 22,48% |
Kas dari operasi | -19,66Â jt | 25,16% |
Kas dari investasi | 34,64Â jt | 73,71% |
Kas dari pembiayaan | 29,15Â jt | 1.485,47% |
Perubahan kas bersih | 44,13Â jt | 1.081,94% |
Arus kas bebas | 3,91Â jt | 127,61% |
Tentang
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Didirikan
1999
Situs
Karyawan
134
